Analysts/Institutional Investor Meet/Con. Call Updates

Date: 2nd November, 2026 Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001. Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Intimation of Investor’s Conference Call Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing here with invitation for Investor’s Conference Call, scheduled to be held on Thursday, 5th November, 2026 at 12:00 noon (IST), to discuss the Company’s financial results and performance for the second quarter and half year ended 30th September, 2026. Please take into your records Thanking you Yours Faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary Hyderabad, November 02, 2026: SMS Pharmaceuticals Ltd, a diversified and integrated pharmaceutical company specialising in APIs and intermediates, will announce its results for the second quarter and half year ended September 30, 2026, on Wednesday, November 04, 2026. The results will be available on the Company’s website, www.smspharma.com/. The Company will hold an earnings call on Thursday, November 05, 2026, at 12 noon IST, where senior management will discuss its results and performance. SMS Pharmaceuticals Q2 & H1 FY27 Earnings Call on Thursday, November 05, 2026, at 12 noon IST Conference Dial-In Information: Diamond Pass: Please click here to pre-register for the call +91 22 6280 1254 Universal Numbers +91 22 7115 8043 Hong Kong – 800964448 Singapore – 8001012045 International Toll Free Numbers UK – 08081011573 US – 18667462133 For any further information, please contact: Company Investor relations SMS Pharmaceuticals Ltd Eqsponent Mr. Thirumalesh Tumma Mr. Aditya Dutta Email: complianceofficer@smspharma.com Email: smspharma.IR@eqsponent.com